Periodic Review, Requalification & Change Control for Qualified Equipment
Capital Projects, Upgrades and Their Impact on Existing IQ OQ PQ Status The pharmaceutical industry continually faces challenges from evolving technologies and regulatory landscapes. With the constant push for innovation and efficiency, capital projects such as retrofits and expansions are integral to maintaining compliance and enhancing operational capacity. However, these upgrades necessitate careful consideration of their impact on existing equipment…
Change Control Impact Assessments Focused on Validation and Qualification Status Introduction to Change Control and Validation Status Change control is a critical process in the pharmaceutical industry, primarily regulated under Good Manufacturing Practice (GMP) guidelines established by organizations such as the FDA, EMA, and MHRA. The goal of change control is to systematically evaluate and manage changes to processes, equipment,…
KPI Dashboards for Lifecycle Management of Qualified Equipment and Utilities KPI Dashboards for Lifecycle Management of Qualified Equipment and Utilities Understanding Lifecycle Management in Pharmaceutical Validation Lifecycle management is an essential element in ensuring compliance with regulatory expectations for pharmaceutical validation. The US FDA, EMA, and other regulatory bodies articulate the need for rigorous validation processes that encompass the entire…
Case Studies of Poor Lifecycle Management and Enforcement Actions Case Studies of Poor Lifecycle Management and Enforcement Actions Effective lifecycle management of pharmaceutical equipment and utilities is paramount to ensure compliance with good manufacturing practices (cGMP) and regulatory standards. However, instances of poor lifecycle management can lead to severe consequences for pharmaceutical companies, including regulatory actions from authorities such as…
Training and Governance for Periodic Review and Change Control Committees The governance of lifecycle committees plays a pivotal role in ensuring compliance and operational efficiency within pharmaceutical organizations. With the increasing complexity of regulatory expectations, particularly regarding periodic reviews and change control, understanding the framework governing these committees is essential for professionals in the pharmaceutical industry. Understanding Governance for Lifecycle…
Linking Lifecycle Management to Asset Management and Reliability Programs In the pharmaceutical industry, the rigorous validation processes mandated by regulatory bodies such as the US FDA, EMA, and MHRA are crucial in ensuring that products are manufactured consistently with predetermined quality standards. This regulatory explainer manual provides detailed guidance on the expectations surrounding validation through the lens of lifecycle management,…
Leveraging Historical Qualification Data to Justify Reduced Requalification Scope Leveraging Historical Qualification Data to Justify Reduced Requalification Scope Introduction to Pharmaceutical Validation Regulations The pharmaceutical industry is deeply regulated, with strict expectations for validation processes to ensure products are safe, effective, and manufactured in compliance with Good Manufacturing Practices (cGMP). Various regulatory bodies, including the FDA, European Medicines Agency (EMA),…
Inspection Ready Storyboards for Lifecycle Management and Requalification History Inspection Ready Storyboards for Lifecycle Management and Requalification History In the pharmaceutical industry, maintaining compliance with regulatory standards is crucial. The use of storyboards for lifecycle management is one method to present documentation and events related to equipment qualification and requalification, specifically during inspections. This step-by-step tutorial outlines how to create…